New research has found a potential link between semaglutide use and a rare eye condition called NAION, though more work is needed to prove causation.
New research released on Wednesday suggests that Ozempic and similar medications may have unexpected side effects. Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare condition that can cause blindness called nonarteritic anterior ischemic optic neuropathy . The findings do not prove a causal connection between the two, however, and more research is needed to know for certain, the researchers say.
Compared to people taking other obesity medications, the risk of NAION was over seven times higher for those prescribed semaglutide. “This study’s findings suggest an association between semaglutide and NAION,” the doctors wrote in their paper, published Wednesday in the journal JAMA Ophthalmology. As far as the researchers know, this is the first piece of evidence ever to suggest that semaglutide could raise the risk of NAION.
Health Medical Pharma GLP-1 Receptor Agonist Semaglutide Glucagon-Like Peptide-1 Peptide Therapeutics Anterior Ischemic Optic Neuropathy Non-Arteritic Anterior Ischemic Optic Neuropathy Optic Neuropathy Type 2 Diabetes Diabetes Peptide Hormones Gizmodo
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic to treat arthritis? Why doctors say obesity drugs could cure a host of chronic illnessesOzempic and Wegovy linked to lower risk of alcoholism
Read more »
Maker of Ozempic, Wegovy to build massive facility in North CarolinaRooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Ozempic and Wegovy may reduce inflammation by targeting the brainWeight-loss injections such as Wegovy reduce inflammation in the body by acting on brain cells, according to a study in mice
Read more »
Fake Wegovy and Ozempic warnings: What to knowWHO and Eli Lilly has warned consumers to be cautious of counterfeit versions of popular weight-loss and diabetes drugs like Wegovy, Ozempic being sold online.
Read more »